BROS vs LEXXW · P/E 105, rev $1.02B vs rev $705.9K
Dutch Bros Inc (BROS) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the BROS and LEXXW stock pages for the full models.
Not investment advice.